PharmaKB logo
Company Reports
Company Reports
Drug Reports
Drug Reports
Disease Reports
Disease Reports
Sets
Sets
Favorites
Favorites
Log in
Log in
AboutPricing
Drug ReportsSomatropin
Humatrope, Nutropinaq(somatropin)
Genotropin, Humatrope, Norditropin, Nutropin, NutropinAq, Omnitrope, Serostim, Zomacton (somatropin) is a protein pharmaceutical. Somatropin was first approved as Humatrope on 1986-10-16. It is used to treat cachexia, dwarfism, heart failure, noonan syndrome, and prader-willi syndrome amongst others in the USA. It has been approved in Europe to treat growth, pituitary dwarfism, prader-willi syndrome, and turner syndrome. The pharmaceutical is active against growth hormone receptor.
Download report
Favorite
Events Timeline
Commercial
Clinical
Drug
Target
Variants
Financial
Trends
Safety
Events Timeline
5D
1M
3M
6M
YTD
1Y
2Y
5Y
Max
Events
FDA approval date
EMA approval date
Patent expiration date
Study first post date
Last update post date
Start date
Primary completion date
Completion date
Results first post date
Plot placeholder
Mock data
Subscribe for the real data
Commercial
Therapeutic Areas
Therapeutic Area
MeSH
musculoskeletal diseasesD009140
nervous system diseasesD009422
urogenital diseasesD000091642
cardiovascular diseasesD002318
hereditary congenital and neonatal diseases and abnormalitiesD009358
skin and connective tissue diseasesD017437
nutritional and metabolic diseasesD009750
endocrine system diseasesD004700
signs and symptoms pathological conditionsD013568
physiological phenomenaD010829
Trade Name
FDA
EMA
Genotropin, Humatrope, Norditropin, Omnitrope, Serostim, Zomacton (discontinued: Accretropin, Genotropin, Humatrope, Norditropin, Nutropin, Omnitrope, Saizen, Serostim, Zomacton)
Drug Products
FDA
EMA
Reference product - 351(a)
Reference product - 351(a)
Interchangeable product - 351(k)
Interchangeable product - 351(k)
Biosimilar product - 351(k)
Biosimilar product - 351(k)
Somatropin
Tradename
Proper name
Company
Number
Date
Products
SerostimsomatropinEMD SeronoN-20604 RX1996-08-23
3 products
HumatropesomatropinEli LillyN-19640 RX1999-02-04
3 products
ZomactonsomatropinFerring PharmaceuticalsN-19774 RX2002-01-04
2 products
NorditropinsomatropinNovo NordiskN-21148 RX2010-03-01
4 products
GenotropinsomatropinPharmacia & Upjohn Company LLCN-20280 RX1995-08-24
12 products
OmnitropesomatropinSandozN-21426 RX2006-05-30
3 products
Show 11 discontinued
Labels
FDA
EMA
Brand Name
Status
Last Update
genotropinBiologic Licensing Application2025-07-16
humatropeBiologic Licensing Application2025-07-09
norditropinBiologic Licensing Application2025-07-07
norditropin norditropin nordiflex2008-11-10
nutropin aq2006-07-11
nutropin aq nuspin 10 nutropin aq nuspin 20 nutropin aq nuspin 5Biologic Licensing Application2025-07-18
nutropin aq nuspin 10 nutropin aq nuspin 20 nutropin aq nuspin 5 nutropin aq pen 10 nutropin aq pen 20New Drug Application2019-12-17
nutropin aq nutropin aq nuspin 10 nutropin aq nuspin 20 nutropin aq nuspin 5 nutropin aq pen 10 nutropin aq pen 20New Drug Application2013-10-29
omnitropeBiologic Licensing Application2025-07-10
serostimBiologic Licensing Application2022-02-02
Show 1 more
Indications
FDA
EMA
Indication
Ontology
MeSH
ICD-10
heart failureEFO_0003144D006333I50
prader-willi syndromeOrphanet_739D011218Q87.11
cachexia—D002100R64
turner syndromeOrphanet_881D014424Q96
noonan syndromeOrphanet_648D009634Q87.19
dwarfism—D004392E34.31
Agency Specific
FDA
EMA
Expiration
Code
somatropin, Norditropin, Novo Nordisk Inc.
2114-05-31Orphan excl.
somatropin, Humatrope, Eli Lilly and Company
2113-11-01Orphan excl.
somatropin, Genotropin, Pharmacia & Upjohn Company LLC
2108-07-25Orphan excl.
somatropin, Nutropin, Genentech, Inc.
2103-12-30Orphan excl.
somatropin, Serostim, EMD Serono, Inc.
2103-08-23Orphan excl.
Patent Expiration
No data
ATC Codes
H: Systemic hormonal preparations, excl. sex hormones and insulins
— H01: Pituitary and hypothalamic hormones and analogues
— H01A: Anterior pituitary lobe hormones and analogues
— H01AC: Somatropin and somatropin agonists
— H01AC01: Somatropin
HCPCS
Code
Description
J2941
Injection, somatropin, 1 mg
Clinical
Clinical Trials
1165 clinical trials
View more details
Plot placeholder
Mock data
Subscribe for the real data
Indications Phases 4
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
InfertilityD007246EFO_0000545——211—3
HypogonadismD007006—E23.0———1—1
Short bowel syndromeD012778—K90.82———1—1
Intestinal failureD000090124—K90.83———1—1
Indications Phases 3
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
Hiv infectionsD015658EFO_0000764B20—34——5
Laron syndromeD046150Orphanet_633E34.3211—2—14
Pituitary dwarfismD004393EFO_1001109E23.0113——4
HypopituitarismD007018EFO_0001380E23.0—11——1
DwarfismD004392—E34.31—11——1
LipodystrophyD008060—E88.1——1——1
Hiv wasting syndromeD019247EFO_0007312———1——1
Indications Phases 2
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
Primary ovarian insufficiencyD016649EFO_0004266E28.3—1———1
HivD006678—O98.7—1———1
Acquired immunodeficiency syndromeD000163EFO_0000765B20—1———1
Indications Phases 1
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
Failure to thriveD005183——1————1
Healthy volunteers/patients———1————1
Indications Without Phase
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
Pituitary neoplasmsD010911——————11
AdenomaD000236——————11
Pituitary diseasesD010900—E23.7————11
Epidemiology
Epidemiological information for investigational and approved indications
View more details
Drug
General
Drug common nameSomatropin
INNsomatropin
Description
Accretropin, Genotropin, Humatrope, Norditropin, Nutropin, Nutropin AQ, Omnitrope, Saizen, Serostim, Zomacton, Zorbtive/Serostim, NutropinAq (somatropin) is a protein pharmaceutical. Somatropin was first approved as Accretropin on 2001-02-15. It is used to treat cachexia, dwarfism, heart failure, noonan syndrome, and prader-willi syndrome amongst others in the USA. It has been approved in Europe to treat pituitary dwarfism, prader-willi syndrome, and turner syndrome. The pharmaceutical is active against growth hormone receptor.
Classification
Protein
Drug classtricyclic compounds; growth hormone derivatives; atropine derivatives
Image (chem structure or protein)Loading
Structure (InChI/SMILES or Protein Sequence)—
Identifiers
PDB—
CAS-ID—
RxCUI—
ChEMBL IDCHEMBL1201621
ChEBI ID—
PubChem CID—
DrugBank—
UNII IDNQX9KB6PCL (ChemIDplus, GSRS)
Target
Agency Approved
GHR
GHR
Organism
Homo sapiens
Gene name
GHR
Gene synonyms
NCBI Gene ID
2690
Protein name
growth hormone receptor
Protein synonyms
GH receptor, growth hormone binding protein, mutant growth hormone receptor, serum binding protein, Somatotropin receptor
Uniprot ID
Q9HCX2
Mouse ortholog
Ghr (14600)
growth hormone receptor (P16882)
Alternate
No data
Variants
No data
Financial
Revenue by drug
$
€
£
â‚£
Genotropin – Pfizer
Plot placeholder
Mock data
Subscribe for the real data
Plot placeholder
Mock data
Subscribe for the real data
Tabular view
Estimated US medical usage
Somatropin
Total medical expenditures per year (USD, in millions)
Plot placeholder
Mock data
Subscribe for the real data
Number of persons purchased
Plot placeholder
Mock data
Subscribe for the real data
Number of purchases
Plot placeholder
Mock data
Subscribe for the real data
Refill frequency
Plot placeholder
Mock data
Subscribe for the real data
Price per prescription (USD)
Plot placeholder
Mock data
Subscribe for the real data
Tabular view
Trends
PubMed Central
Top Terms for Disease or Syndrome:
Plot placeholder
Mock data
Subscribe for the real data
Additional graphs summarizing 16,843 documents
View more details
Safety
Black-box Warning
No Black-box warning
Adverse Events
Top Adverse Reactions
Plot placeholder
Mock data
Subscribe for the real data
87,328 adverse events reported
View more details
© 2020-2025 Collaborative Drug Discovery Inc. (CDD) | Terms of Use